Humacyte, Inc.
(HUMA)Financial Statements · SEC EDGAR XBRL
Revenue
$2.0M
Net Income
-$40.8M
+72.5%
EPS
$-0.26
+79.4%
Gross Margin
-376.1%
Op. Income
-$108.1M
+5.5%
FCF
-$105.9M
-6.3%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Interest Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)